# Walgreens Boots Alliance, Inc. – Consensus ‘hold’ rating and 30.3% Upside Potential

- Link: https://www.directorstalkinterviews.com/walgreens-boots-alliance-inc.consensus-hold-rating-and-30.3-upside-potential/4121129313
- Published: 2023-10-12T12:34:25+01:00
- Author: Charlotte Edwards

**Walgreens Boots Alliance, Inc.** which can be found using ticker (WBA) now have
13 analysts in total covering the stock. The consensus rating is pointing to ‘hold’.
The target price High/Low ranges between 45 and 22 suggesting an average Analsyt
target price of $29.15. Now with the previous closing price of $22.38 this now indicates
there is a potential upside of 30.3%. Also worth taking note is the 50 day moving
average now sits at $24.52 and the 200 moving average now moves to $31.31. The market
capitalization for the company is 19.51B. The current share price for the company
is: 22.6 USD

 The potential market cap would be $25,411,425,962 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of 157.64 and
a 0.67% return on assets.

Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing
company. The Company operates through three segments: U.S. Retail Pharmacy, International,
and U.S. Healthcare. The Company’s U.S. Retail Pharmacy segment includes the Walgreens
business, which includes the operations of retail drug stores, health and wellness
services, and specialty and home delivery pharmacy services, and its equity method
investment in AmerisourceBergen. Its International segment consists of pharmacy-
led health and beauty retail businesses outside the United States and a pharmaceutical
wholesaling and distribution business in Germany. Its portfolio of consumer brands
include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico
and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-
enabled healthcare business that engages consumers through a personalized, omni-
channel experience across the care journey.

Share on: